1. VEGF levels in CSF and serum in mild ALS patients
Gao Lina , Zhou Shaodan , Cai Haowei , Gong Zhongying , Zang Dawei  
Journal of the Neurological Sciences 
Volume 346, Issue 1, Pages (November 2014)
DOI: /j.jns
Copyright © 2014 Elsevier B.V. Terms and Conditions

2. Fig. 1 VEGF levels of ALS patients and controls.
Levels of VEGF in the CSF (A) and serum (B) of ALS patients and control subjects. * shows that the VEGF levels in CSF and serum are significantly higher in ALS patients than those in control subjects (P=0.009 and P<0.001, respectively).
Journal of the Neurological Sciences  , DOI: ( /j.jns )
Copyright © 2014 Elsevier B.V. Terms and Conditions

3. Fig. 2
Correlations between CSF (A) and serum (B) VEGF levels of ALS patients and their duration.
A, B: The correlations between CSF and serum VEGF levels with the duration of ALS patients are positive and significant (P=0.0432, P=0.0219, respectively).
Journal of the Neurological Sciences  , DOI: ( /j.jns )
Copyright © 2014 Elsevier B.V. Terms and Conditions

4. Fig. 3
CSF and serum VEGF levels of ALS patients in duration (0–12months) subgroup and duration (12+months) subgroup.
* shows that the VEGF levels in CSF (A) and serum (B) of ALS patients are significantly higher in duration (12+months) subgroup than those in duration (0–12months) subgroup (P=0.040 and P=0.039, respectively).
Journal of the Neurological Sciences  , DOI: ( /j.jns )
Copyright © 2014 Elsevier B.V. Terms and Conditions

5. Fig. 4
Correlations between CSF (A) and serum (B) VEGF levels of ALS patients and their disease progression rate (DPR).
A, B: The correlations between CSF and serum VEGF levels with the disease progression rate (DPR) of ALS patients are negative and significant (P=0.0482, P=0.0353, respectively).
Journal of the Neurological Sciences  , DOI: ( /j.jns )
Copyright © 2014 Elsevier B.V. Terms and Conditions

6. Fig. 5
CSF and serum VEGF levels of ALS patients in DPR (0–1) subgroup and DPR (1+) subgroup.
* shows that the VEGF levels in serum (B) of ALS patients are significantly higher in DPR (0–1) subgroup than those in DPR (1+) subgroup (P=0.025).
Journal of the Neurological Sciences  , DOI: ( /j.jns )
Copyright © 2014 Elsevier B.V. Terms and Conditions